Trials / Conditions / High Bleeding Risk

High Bleeding Risk

10 registered clinical trials studyying High Bleeding Risk — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes NCT07383155	Shenyang Northern Hospital	Phase 4
Recruiting	Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB NCT06535568	Fondazione Ricerca e Innovazione Cardiovascolare ETS	N/A
Not Yet Recruiting	Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR NCT06763744	Samsung Medical Center	Phase 4
Recruiting	Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure NCT07125417	OCEAN-SHD Study Group	Phase 4
Unknown	Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk NCT05240781	Instituto Nacional de Cardiologia Ignacio Chavez	N/A
Terminated	Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty NCT04885816	Instituto Nacional de Cardiologia Ignacio Chavez	N/A
Completed	Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population NCT04500912	Pieter C.Smits	N/A
Completed	Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbrevi NCT03023020	ECRI bv	N/A
Active Not Recruiting	LEADERS FREE II: BioFreedom™ Pivotal Study NCT02843633	Biosensors Europe SA	N/A
Completed	Efficacy of Intermittent Pneumatic Compression (IPC) on Venous Thromboembolism Incidence in Intensive Care Uni NCT00740844	University Hospital, Brest	Phase 3